Company facts
- Headquarters
- Burlington, Massachusetts
- Most recent report
- 8-K, filed Oct 15, 2026
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1158895
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 47
News 8 of 81
Prospectuses and Registrations 4
Proxies 8 of 13
- DEFA14A Extra proxy material Apr 14, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 14, 2026
- DEFA14A Extra proxy material May 9, 2025
- DEFA14A Extra proxy material Apr 17, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 17, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 16, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 14, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 14, 2022
Ownership 8 of 836
- 4 Insider reported a trade Sep 8, 2026
- 4 Insider reported a trade Sep 8, 2026
- 4 Insider reported a trade Sep 8, 2026
- 4 Insider reported a trade Sep 8, 2026
- 4 Insider reported a trade Sep 8, 2026
- 4 Insider reported a trade Sep 8, 2026
- 4 Insider reported a trade Sep 8, 2026
- 4 Insider reported a trade Sep 8, 2026
Other 8 of 19
- SD Conflict minerals disclosure May 29, 2026
- ARS Annual report sent to shareholders Apr 14, 2026
- SD Conflict minerals disclosure May 30, 2025
- SD Conflict minerals disclosure May 31, 2024
- ARS Annual report sent to shareholders Apr 16, 2024
- SD Conflict minerals disclosure May 31, 2023
- ARS Annual report sent to shareholders Apr 14, 2023
- SD Conflict minerals disclosure May 31, 2022
Everything here comes from Lemaitre Vascular Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.